Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19
NCT04403880
·
clinicaltrials.gov ↗
COMPLETED
Status
760
Enrollment
NETWORK
Sponsor class
Conditions
SARS-CoV-2
COVID-19
Interventions
OTHER:
Sample collection
Sponsor
HIV Vaccine Trials Network
Collaborators
[object Object]
[object Object]